Andreas Halvorsen - Viking Global Investors
Holding/activity history for Atyr Pharma Inc (LIFE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2019 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2019 Q2 | 3,209,955 | 0.01 | $0.37 | $1,176,000 | SEC | ||
| 2019 Q1 | 3,209,955 | 0.01 | Add 131.88% | <0.01 | $0.55 | $1,766,000 | SEC |
| 2018 Q4 | 1,384,300 | <0.01 | $0.50 | $686,000 | SEC | ||
| 2018 Q3 | 1,384,300 | 0.01 | $0.81 | $1,125,000 | SEC | ||
| 2018 Q2 | 1,384,300 | 0.01 | $0.91 | $1,260,000 | SEC | ||
| 2018 Q1 | 1,384,300 | 0.02 | $2.65 | $3,668,000 | SEC | ||
| 2017 Q4 | 1,384,300 | 0.03 | Reduce 22.13% | 0.01 | $3.50 | $4,845,000 | SEC |
| 2017 Q3 | 1,777,784 | 0.06 | Buy | 0.06 | $5.05 | $8,978,000 | SEC |